Dysbiosis of Gut Microbiota in a selected population of Italian Parkinson’s Disease patients
Objective: Our main objective was to investigate dysbiosis of gut microbiota in a selected population of Parkinson’s disease (PD) patients from center-south of Italy, examining…The Level of Neuroendocrine Hormones in Parkinson´s Disease and their Potential Role as Biomarkers : A Pilot Study
Objective: To elucidate the role of neuroendocrine hormones in Parkinson’s disease (PD) and evaluate their potential utilization as biomarkers. Background: A growing body of evidence,…Gastrointestinal symptoms as a risk factor for the appearance of motor fluctuations in patients with advanced Parkinson disease
Objective: Gastrointestinal alterations in patients with Parkinson`s Disease (EP) provoke alterations in the absorption of levodopa that facilitates the development of motor fluctuations. Study the…Clostridium Difficile Infection and Risk of Parkinson’s Disease: A Swedish Population-Based Cohort Study
Objective: To examine whether individuals with a history of Clostridium difficile (C. diff) infection have an elevated risk of developing Parkinson’s disease (PD). Background: The…Antibiotic exposure and Risk for Parkinson’s Disease
Objective: To determine whether antibiotic exposure is associated with Parkinson's disease (PD). Background: Environmental exposures affect the risk of PD and it has been proposed…Outcomes of Percutaneous Endoscopic Gastrostomy (PEG) Feeding in Parkinson’s
Objective: To describe outcomes of PEG feeding in Parkinson's and related disorders. Background: PEG feeding provides a means of getting food, liquid and medication safely…Gastrointestinal symptoms predict cognitive decline in Parkinson’s Disease
Objective: To explore the predictive value of non-motor symptoms on the cognitive decline of patients with Parkinson’s disease (PD) in a three-year follow up. Background:…Gut microbiota geography in Parkinson’s disease in the world
Objective: The 16 rRNA analysis and the shotgun metagenome analysis in our cohort were compared with 5 previous reports by others. Background: In PD patients,…Unveiling the function of altered gut microbiota composition in Parkinson’s disease
Objective: To investigate the gut microbiome and metabolome in Parkinson’s disease (PD). Background: Recent evidence revealed that gut microbes promote alpha-synuclein pathology and motor deficits…GASTROPARK: Multicenter study on the efficacy of dopamine agonists for gastrointestinal symptoms in Parkinson’s disease
Objective: Main: To assess the modification of gastrointestinal symptoms in patients with Parkinson's disease before and after the introduction of dopamine agonists. Secondary: (1) To…
- « Previous Page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- 10
- Next Page »